Cure Alveolar Soft Part Sarcoma International (iCureASPS)

2009 ASCO Annual Meeting Abstracts
http://www.abstract.asco.org/CatAbstView_65_78_AA.html

For us there is an abstract of the Prof. Judson about development of his cediranib study in ASPS patients some of them we know personally
Activity of cediranib, a highly potent and selective VEGF signaling inhibitor, in alveolar soft part sarcoma.
http://www.abstract.asco.org/AbstView_65_30688.html
Full text with the time to progression and progression-free survival will be calculated and available at the time of presentation, I hope to get it later, our oncologist is attending.

Olga,
Thanks for posting this. Our oncologist is also attending this meeting and I look forward to
our next appt. It seems this will be a great opportunity for them to share info. and learn from
one another about the trial data. We are still participating in ARQ.
Cindy